HIV 1 News and Research

RSS

Donors pledge nearly $12b for Global Fund, missing lowest funding target

Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, "higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world," the Financial Times reports.

7 Oct 2010

HHS partners with PEPFAR to invest $130M for African medical education

The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief with a plan to invest $130 million over five years to transform African medical education and dramatically increase the number of health care workers.

7 Oct 2010

Sudden cardiac arrest survivors to gather at SCAA Annual Meeting

A nationwide gathering of sudden cardiac arrest (SCA) survivors, emergency responders and civilian rescuers will mark SCA Awareness Month with a Survivors & Heroes Celebration on Friday, October 8 at 6:00 p.m. at the Marriott City Center in Pittsburgh, Pennsylvania.

7 Oct 2010

3.5 million Calif. residents eligible for tax credits in future exchange; N.Y. prescription drug aid for seniors cut back; Idaho trims dental providers in Medicaid

An estimated 3.5 million Californians would be eligible for federal tax credits to slash the cost of their health coverage when they begin buying policies through a new statewide insurance marketplace in 2014, a study released Tuesday found.

7 Oct 2010

Teen sex on the rise and so are STIs: Survey

A survey of 8,800 Australian year 10 and year 12 students in 300 schools around Australia was taken in three snapshots between 1997 and 2008. It was found that with the rise of risky alcohol consumption among Australia's teenagers there is also a surge of sex “under the influence” and number of sexual partners and unsafe and unprotected intercourse. However, the awareness of HIV/AIDS remained high.

6 Oct 2010

Lumosity.com launches Italian version of cognitive training service

Lumosity.com, the leading online provider of games that improve brain performance, announced today the launch of an Italian version of their cognitive training service -- i.lumosity.com/it. The translation of the site into Italian was sponsored by Abbott Laboratories. Abbott also sponsored hundreds of memberships to make the Lumosity.com cognitive training program available to doctors and patients throughout Italy in an effort to raise awareness about the cognitive deficits associated with HIV/AIDS.

6 Oct 2010

Miller-Mccune examines impact of limited access to schistosomiasis drug in Africa

Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel the only commercially available treatment for the disease.

6 Oct 2010

Obama administration expected to announce $4B pledge to Global Fund

The Obama administration is expected on Tuesday to announce a large increase in its pledge to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and to call for reform of the organization," the Wall Street Journal reports.

6 Oct 2010

RDI launches HIV-TRePS system to predict patients’ response to HIV drugs

A ground-breaking system for predicting how individual patients with HIV and AIDS will respond to different drugs is launched today by RDI, a UK-based not-for-profit research group. The experimental system, called the HIV Treatment Response Prediction System (HIV-TRePS), is available free of charge over the Internet and helps physicians select the best treatment for their patients.

6 Oct 2010

AHF applauds Obama administration for reasserting U.S. leadership in contributions to fight global AIDS

AIDS Healthcare Foundation (AHF) today lauded the Obama administration's announcement that it will seek $4 billion for the Global Fund to Fight HIV/AIDS, Malaria and Tuberculosis over the next three years—a 38% increase over what has been provided in the previous three-year period. The U.S. also urged better management of grants by participating countries, as well as increased accountability and efficiency by the Global Fund.

6 Oct 2010

Global health fund to get big boost from U.S.

The Wall Street Journal: "The Obama administration is expected on Tuesday to announce a large increase in its pledge to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and to call for reform of the organization. The pledge of $4 billion over the next three fiscal years to the Geneva-based organization comes as governments and donors around the world have slowed increases in spending to combat HIV/AIDS, with weaker economies straining budgets."

6 Oct 2010

Mass. hospital sale talks seeking to protect employee retirement plans; Conn. Gov. ask for waiver in preexisting insurance plan

Representatives of Caritas Christi Health Care, the private equity firm seeking to buy it, and the attorney general's office are working on a tentative agreement to protect the retirement plans of 13,000 employees and keep the chain's hospitals open for at least five years.

6 Oct 2010

Chevron Corporation raises $25 million for Global Fund

Chevron Corporation today announced that it will commit an additional $25 million to The Global Fund to Fight AIDS, Tuberculosis and Malaria, raising its 6-year investment in the organization to $55 million.

6 Oct 2010

Profectus BioSciences awarded $3.1M Fast Track SBIR grant to develop prophylactic vaccine against HIV

Profectus BioSciences, Inc., a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases, today announced the award of a Fast Track SBIR from the Division of AIDS, National Institutes of Health for $3.1M to support the development of the Company's Transition State Vaccine (TSV) technology for a prophylactic HIV Vaccine.

6 Oct 2010

Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1

Altravax, Inc. announced today that it has been awarded two SBIR grants totaling $1.2 million from the NIH's National Institute of Allergy and Infectious Diseases for research on antibody-inducing vaccines for HIV-1.

6 Oct 2010

NSSHB study provides update on contemporary Americans' sexual behaviors

Findings from the largest nationally representative study of sexual and sexual-health behaviors ever fielded, conducted by Indiana University sexual health researchers, provides an updated and much needed snapshot of contemporary Americans' sexual behaviors, including a description of more than 40 combinations of sexual acts that people perform during sexual events, patterns of condom use by adolescents and adults, and the percentage of Americans participating in same-sex encounters.

5 Oct 2010

FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Atazanavir Sulfate Capsules, 150 mg and 300 mg. This product will be eligible for purchase outside the U.S. in certain developing countries.

5 Oct 2010

NIH awards $4 million grant to develop novel genetic strategy for combating tuberculosis

William R. Jacobs, Jr., Ph.D., professor of microbiology & immunology and of genetics at Albert Einstein College of Medicine of Yeshiva University, who is also a Howard Hughes Medical Institute (HHMI) investigator, has been awarded a three-year, $4 million grant from the National Institutes of Health to develop a novel genetic strategy for combating tuberculosis (TB). TB causes almost two million deaths each year, making it the world's most deadly bacterial infection.

5 Oct 2010

cobas TaqScreen DPX Test now available with CE Mark: Roche

Roche announced today that the cobas TaqScreen DPX Test for use on the cobas s 201 system is now available with the CE Mark. It is the first IVD test to offer complete coverage of all human genotypes of parvovirus B19 (B19V) and hepatitis A virus (HAV) in one assay.

5 Oct 2010

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Gen-Probe Incorporated announced today that the Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its APTIMA® Trichomonas vaginalis assay on the fully automated TIGRIS® system.

5 Oct 2010

HIV 1 News and Research

Donors pledge nearly $12b for Global Fund, missing lowest funding target

HHS partners with PEPFAR to invest $130M for African medical education

Sudden cardiac arrest survivors to gather at SCAA Annual Meeting

3.5 million Calif. residents eligible for tax credits in future exchange; N.Y. prescription drug aid for seniors cut back; Idaho trims dental providers in Medicaid

Teen sex on the rise and so are STIs: Survey

Lumosity.com launches Italian version of cognitive training service

Miller-Mccune examines impact of limited access to schistosomiasis drug in Africa

Obama administration expected to announce $4B pledge to Global Fund

RDI launches HIV-TRePS system to predict patients’ response to HIV drugs

AHF applauds Obama administration for reasserting U.S. leadership in contributions to fight global AIDS

Global health fund to get big boost from U.S.

Mass. hospital sale talks seeking to protect employee retirement plans; Conn. Gov. ask for waiver in preexisting insurance plan

Chevron Corporation raises $25 million for Global Fund

Profectus BioSciences awarded $3.1M Fast Track SBIR grant to develop prophylactic vaccine against HIV

Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1

NSSHB study provides update on contemporary Americans' sexual behaviors

FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA

NIH awards $4 million grant to develop novel genetic strategy for combating tuberculosis

cobas TaqScreen DPX Test now available with CE Mark: Roche

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News